- Previous Close
8,460.00 - Open
8,510.00 - Bid 8,350.00 x --
- Ask 8,370.00 x --
- Day's Range
8,300.00 - 8,510.00 - 52 Week Range
8,300.00 - 12,690.00 - Volume
16,571 - Avg. Volume
27,444 - Market Cap (intraday)
31.806B - Beta (5Y Monthly) 0.80
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield 75.00 (0.90%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
--
Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea.
www.dsmbio.co.krRecent News: 036480.KQ
View MorePerformance Overview: 036480.KQ
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 036480.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 036480.KQ
View MoreValuation Measures
Market Cap
31.81B
Enterprise Value
43.18B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.34
Price/Book (mrq)
0.90
Enterprise Value/Revenue
1.81
Enterprise Value/EBITDA
43.62
Financial Highlights
Profitability and Income Statement
Profit Margin
-7.43%
Return on Assets (ttm)
-1.58%
Return on Equity (ttm)
-4.88%
Revenue (ttm)
23.8B
Net Income Avi to Common (ttm)
-1.77B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
9.05B
Total Debt/Equity (mrq)
58.12%
Levered Free Cash Flow (ttm)
1.54B